Angiotensin II for low blood pressure after heart surgery
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests a medication called angiotensin II (brand name Giapreza) to see if it can raise blood pressure in people who have dangerously low blood pressure after heart surgery. If you or a loved one is in the hospital after heart surgery with low blood pressure that isn't getting better with standard treatments, this study may be an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have very low blood pressure (below 65 mmHg) after heart surgery that used a heart-lung machine
- You are not taking certain blood pressure medications (ACE inhibitors or ARBs) right now
- You are not on high-dose steroids
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a medicine called angiotensin II during heart surgery can help prevent acute kidney injury (a sudden drop in kidney function). It is for adults having certain types of heart surgery who have a higher risk of kidney problems.
This study looks at how a blood-pressure hormone system (RAAS) changes during coronary artery bypass surgery. It may help researchers understand better how to manage blood pressure and heart stress around the time of surgery.
This trial tests whether a medication called vericiguat, given around the time of heart surgery, can help protect your heart and prevent heart failure complications. You'll receive the study drug or a placebo before and after surgery and be monitored for 6 months.
This study tests a method to safely reduce (wean) norepinephrine, a blood-pressure–support medicine, in people who develop low blood pressure after heart surgery. It uses a monitoring index to help decide when it may be safer to lower the dose, aiming to improve recovery and reduce risks.
This study tests an IV medicine called angiotensin II (Giapreza) to raise blood pressure in children who are very sick and not responding to standard treatments. It aims to see if this medicine can help stabilize blood pressure and improve outcomes.
This trial tests if starting Angiotensin II early, instead of other blood pressure medications, can help heart surgery patients maintain safe blood pressure. It may be an option if you have low blood pressure after surgery despite receiving fluids.
Hear when a new Cardiopulmonary Bypass trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.